Nazareth Hospital Evaluates a Patient's Heart While Treating Cancer

  • Share:
August 20, 2019
Northeast Philadelphia – (August 19, 2019) – Nazareth Hospital takes precautions to protect the heart from cardiotoxicity while treating patients with cancer. Cardiotoxicity, or damage to the heart muscle, can occur when patients receive chemotherapy and anti-cancer medications. Nazareth Hospital’s enhanced echocardiogram technology with strain imaging can detect preliminary signs of heart damage, so doctors can intervene early — for example, with a change in therapy — and prevent the heart from getting weaker.
 
“Fortunately, cancer treatment has evolved, and oncologists now have multiple tools in treating cancer,” said Sonela Skenderi, DO, FACC, a cardiologist at Nazareth Hospital.
 
Before beginning treatment for cancer at Nazareth Hospital, a care team, including a cardiologist, evaluates the patient’s heart and may perform an echocardiogram scan to detect potential damage to the heart muscle. Nazareth Hospital doctors also assess a patient’s risk for cardiotoxicity to prevent this complication during and after cancer treatment.
 
Risk factors for cardiotoxicity include a history of heart disease, obesity, diabetes, smoking, high blood pressure, high cholesterol and being 65 years of age or older. The most common symptoms of cardiotoxicity include shortness of breath, heart palpitations, chest pain and swelling of the legs.
 
A cardiologist may also suggest lifestyle changes and medications, like aspirin, to protect the heart during and after treatment.
 
Screening for potential heart disease before chemotherapy is essential to preventing cardiotoxicity. For more information on cardiotoxicity and cancer care at Nazareth Hospital, visit trinityhealthma.org.
 
###
About Nazareth Hospital
Founded in 1940, Nazareth Hospital is guided by its Catholic-health core values of reverence, stewardship, integrity, justice and commitment to the underserved. Located in Northeast Philadelphia, and with 205 licensed beds and 28 skilled nursing beds, Nazareth Hospital is a community teaching hospital and provides a full array of healthcare services, including emergency care, surgery, vascular services, wound care services, cardiac care, orthopedic and rehabilitation services, and cancer care. Nazareth Hospital is a nationally certified Primary Stroke Center and Chest Pain Center and has earned national accreditations for heart failure care and PCI. Trinity Health Mid-Atlantic is a Regional Health System that includes Mercy Catholic Medical Center – Mercy Fitzgerald Campus in Darby, Pa.; Mercy Catholic Medical Center – Mercy Philadelphia Campus in West Philadelphia; Nazareth Hospital in Northeast Philadelphia; Saint Francis Healthcare in Wilmington, Del.; St. Mary Medical Center in Langhorne, Pa. and home health and LIFE programs. Trinity Health Mid-Atlantic is a member of Trinity Health, one of the largest multi-institutional Catholic health care delivery systems in the nation.
 
About Trinity Health Mid-Atlantic
Trinity Health Mid-Atlantic is a Regional Health System that includes Mercy Catholic Medical Center – Mercy Fitzgerald Campus in Darby, Pa.; Mercy Catholic Medical Center – Mercy Philadelphia Campus in West Philadelphia; Nazareth Hospital in Northeast Philadelphia; Saint Francis Healthcare in Wilmington, Del.; St. Mary Medical Center in Langhorne, Pa., and home health and LIFE programs throughout the region. These entities include hospitals, associated clinics, medical offices, specialized facilities, affiliated institutions and foundations serving together in the spirit of the Gospel as a compassionate and transforming healing presence within their communities. Trinity Health Mid-Atlantic is a member of Trinity Health.
 
Contact:
Christy McCabe
(215) 962-9893